EUVIMEDEUVIMED entdecken
Editorial

Voices in Molecular Pharmaceutics : Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models

Niloufar Salehi iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00687 ↗

Kurz gefasst

Editorial in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Niloufar Salehi. Beteiligte Einrichtung: Synthetic Molecule Design & Development, Lilly Technology Center, Eli Lilly and Company, 1223 West Morris Street, Indianapolis, Indiana 46221, United…. Hauptthemen laut MEDLINE: Pharmacy, Biological Products.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

I am an Advisor in the Synthetic Molecule Design and Development organization at Eli Lilly & Company based in Indianapolis, IN.Along with my team of colleagues, I support pharmaceutical drug product design by developing and utilizing physiologically based dissolution and absorption models.Through integration of data from various sources, such as measured physicochemical drug properties, in vitro assays, and clinical observations, we can gain a detailed understanding of how drugs are absorbed after oral administration.Some of the key deliverables of my role are mechanistic mass transfer model development, particle size target recommendations, food effect predictions, proton pump inhibitor effect predictions, and relative bioavailability risk assessments.I collaborate closely with a multidisciplinary team of experts, including pharmacologists, formulation scientists, analytical chemists, chemical engineers, solid-state scientists, and regulatory professionals.Together, we evaluate preclinical and clinical data, conduct in vitro and in vivo studies, and analyze the results to provide a comprehensive assessment of drug product performance.Our work as biopharmaceutical modeling scientists helps in the rational design and optimization of dosage forms, and robust manufacturing platforms.This work improves the chance of success for developmental drugs in clinical trials and has the potential to improve patients' lives through thoughtful product design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacyBiological ProductsBiopharmaceutics

Substanzen

Biological Products

Autor:innen und Institutionen

  • Synthetic Molecule Design & Development, Lilly Technology Center, Eli Lilly and Company, 1223 West Morris Street, Indianapolis, Indiana 46221, United States.

ORCID-Profile: Niloufar Salehi

Zitieren

APA

Salehi, N. (2023). Voices in Molecular Pharmaceutics : Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00687

Vancouver

Salehi N. Voices in Molecular Pharmaceutics : Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00687

BibTeX
@article{Salehi2023,
  author = {Salehi, Niloufar},
  title = {Voices in Molecular Pharmaceutics : Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00687}
}
Kostenlos starten →